Organization: National Research Council Canada
Year: 2022
Month: February
Request Number: A-2021-49
Request Summary: All correspondence from June 1, 2019 - September 9, 2021, between the National Research Council Canada and the University of British Columbia involving: lipid nanoparticles, Pfizer, National Research Council Canada, Moderna, funding, and Acuitas Therapeutics
Disposition: Disclosed in part
Number of pages: 8